BBOTBRIDGEBIO ONCOLOGY THERAPEUT
CUSIP 107924102 · common stock
1 tracked investor held BRIDGEBIO ONCOLOGY THERAPEUT (BBOT) at the end of Q3 2026, worth $70.5K. The largest holder was Adar1 Capital Management, with 0.0% of its portfolio. Adar1 Capital Management opened a new position this quarter.
Holders · Q3 2026
1
New holders
1
Value held
$70.5K
Quarter-end price (est.)
$4.10
Investors holding BBOT · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.00% | 17,183 | $70.5K | NEW |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Chuck Royce | 0.02% | 384,941 | $2.9M | EXIT |